Author: Rassil, Asmaa; Chougrad, Hiba; Zouaki, Hamid
Title: Graph Neural Networks to Advance Anticancer Drug Design Cord-id: 8rjc4ouu Document date: 2020_5_6
ID: 8rjc4ouu
Snippet: Predicting the activity of chemical compounds against cancer is a crucial task. Active chemical compounds against cancer help pharmaceutical drugs producers in the conception of anticancer medicines. Still the innate way of representing chemical compounds is by graphs, the machine learning algorithms can not handle directly the anticancer activity prediction problems. Dealing with data defined on a non-Euclidean domain gave rise to a new field of research on graphs. There has been many proposals
Document: Predicting the activity of chemical compounds against cancer is a crucial task. Active chemical compounds against cancer help pharmaceutical drugs producers in the conception of anticancer medicines. Still the innate way of representing chemical compounds is by graphs, the machine learning algorithms can not handle directly the anticancer activity prediction problems. Dealing with data defined on a non-Euclidean domain gave rise to a new field of research on graphs. There has been many proposals over the years, that tried to tackle the problem of representation learning on graphs. In this work, we investigate the representation power of Node2vec for embedding learning over graphs, by comparing it to the theoretical framework Graph Isomorphism Network (GIN). We prove that GIN is a deep generalization of Node2vec. We then exert the two models Node2vec and GIN to extract regular representations from chemical compounds and make predictions about their activity against lung and ovarian cancer.
Search related documents:
Co phrase search for related documents- accuracy dataset and loss function: 1
- active compound and local stay: 1
- adam optimizer and loss function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date